These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36987605)

  • 21. Systemic lupus erythematosus and infections.
    Singh BK; Singh S
    Reumatismo; 2020 Nov; 72(3):154-169. PubMed ID: 33213128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes.
    Rúa-Figueroa I; López-Longo FJ; Del Campo V; Galindo-Izquierdo M; Uriarte E; Torre-Cisneros J; Vela P; Tomero E; Narváez J; Olivé A; Freire M; Salgado E; Andreu JL; Martínez-Taboada V; Calvo-Alén J; Hernández-Cruz B; Raya E; Quevedo V; Expósito Pérez L; Fernández-Nebro A; Ibañez M; Pascual-Valls È; Rúa-Figueroa D; Naranjo A; Pego-Reigosa JM
    J Rheumatol; 2020 Feb; 47(2):234-240. PubMed ID: 30988123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of high-grade cervical dysplasia and cervical cancer in women with systemic lupus erythematosus receiving immunosuppressive drugs.
    Feldman CH; Liu J; Feldman S; Solomon DH; Kim SC
    Lupus; 2017 Jun; 26(7):682-689. PubMed ID: 27799438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for herpes zoster infection among Filipinos with systemic lupus erythematosus.
    Zamora LD; Collante MTM; Navarra SV
    Int J Rheum Dis; 2020 Feb; 23(2):197-202. PubMed ID: 31692250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus: a systematic literature review.
    Henegar CE; Eudy AM; Kharat V; Hill DD; Bennett D; Haight B
    Lupus; 2016 May; 25(6):617-26. PubMed ID: 26743322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Infections in systemic lupus erythematosus].
    Massardo L; Martínez ME; Baro M; Figueroa F; Rivero S; Jacobelli S
    Rev Med Chil; 1991 Oct; 119(10):1115-22. PubMed ID: 1845204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic lupus erythematosus-associated acute transverse myelitis: manifestations, treatments, outcomes, and prognostic factors in 20 patients.
    Saison J; Costedoat-Chalumeau N; Maucort-Boulch D; Iwaz J; Marignier R; Cacoub P; Vital-Durand D; Hot A; Tebib J; Aumaitre O; Schleinitz N; Sarrot-Reynauld F; Broussolle C; Sève P
    Lupus; 2015 Jan; 24(1):74-81. PubMed ID: 25117654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort.
    Mok CC; Tse SM; Chan KL; Ho LY
    Lupus; 2018 Apr; 27(5):722-727. PubMed ID: 29087260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group.
    Tsakonas E; Joseph L; Esdaile JM; Choquette D; Senécal JL; Cividino A; Danoff D; Osterland CK; Yeadon C; Smith CD
    Lupus; 1998; 7(2):80-5. PubMed ID: 9541091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature.
    Boddaert J; Huong DLT; Amoura Z; Wechsler B; Godeau P; Piette JC
    Medicine (Baltimore); 2004 Nov; 83(6):348-359. PubMed ID: 15525847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breastfeeding initiation, duration, and reasons for weaning in patients with systemic lupus erythematosus.
    Acevedo M; Pretini J; Micelli M; Sequeira G; Kerzberg E
    Rheumatol Int; 2017 Jul; 37(7):1183-1186. PubMed ID: 28540416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic lupus erythematosus: An approach to pharmacologic interventions.
    El Hussein MT; Wong C
    Nurse Pract; 2023 Jul; 48(7):37-46. PubMed ID: 37368557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus.
    Rúa-Figueroa Í; López-Longo J; Galindo-Izquierdo M; Calvo-Alén J; Del Campo V; Olivé-Marqués A; Pérez-Vicente S; Fernández-Nebro A; Andrés M; Erausquin C; Tomero E; Horcada L; Uriarte E; Freire M; Montilla C; Sánchez-Atrio A; Santos G; Boteanu A; Díez-Álvarez E; Narváez J; Martínez-Taboada V; Silva-Fernández L; Ruiz-Lucea E; Andreu JL; Hernández-Beriain JÁ; Gantes M; Hernández-Cruz B; Pérez-Venegas J; Pecondón-Español Á; Marras C; Ibáñez-Barceló M; Bonilla G; Torrente V; Castellví I; Alegre JJ; Calvet J; Marenco JL; Raya E; Vázquez T; Quevedo V; Muñoz-Fernández S; Rodríguez-Gómez M; Ibáñez J; Pego-Reigosa JM
    Semin Arthritis Rheum; 2017 Aug; 47(1):38-45. PubMed ID: 28259425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic lupus erythematosus. How to manage, when to refer.
    Dall'Era M; Davis JC
    Postgrad Med; 2003 Nov; 114(5):31-7, 40. PubMed ID: 14650091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow as a target organ of systemic lupus erythematosus: analysis of cases with myelofibrosis.
    Üsküdar Cansu D; Üsküdar Teke H; Işiksoy S; Korkmaz C
    Int J Rheum Dis; 2018 May; 21(5):1049-1059. PubMed ID: 29671953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus.
    Fasano S; Messiniti V; Iudici M; Coscia MA; Ciccia F
    Lupus Sci Med; 2023 Jan; 10(1):. PubMed ID: 36631164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).
    Torrente-Segarra V; Salman-Monte TC; Rúa-Figueroa Í; Del Campo V; López-Longo FJ; Galindo-Izquierdo M; Calvo-Alén J; Olivé-Marqués A; Mouriño-Rodríguez C; Horcada L; Bohórquez C; Montilla C; Salgado E; Díez-Álvarez E; Blanco R; Andreu JL; Fernández-Berrizbeitia O; Expósito L; Gantes M; Hernández-Cruz B; Pecondón-Español Á; Lozano-Rivas N; Bonilla G; Lois Iglesias A; Rubio-Muñoz P; Ovalles J; Tomero E; Boteanu A; Narvaez J; Freire M; Vela P; Quevedo-Vila V; Juan Mas A; Muñoz-Fernández S; Raya E; Moreno M; Velloso-Feijoo ML; Soler G; Vázquez-Rodríguez TR; Pego-Reigosa JM;
    Semin Arthritis Rheum; 2020 Aug; 50(4):657-662. PubMed ID: 32505871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corticosteroid dose and the risk of opportunistic infection in a national systemic lupus erythematosus cohort.
    Yang SC; Lai YY; Huang MC; Tsai CS; Wang JL
    Lupus; 2018 Oct; 27(11):1819-1827. PubMed ID: 30103646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute granulocytic leukemia following systemic lupus erythematosus.
    Paolozzi FP; Goldberg J
    Am J Med Sci; 1985 Jul; 290(1):32-5. PubMed ID: 3862339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.